I am a
Home I AM A Search Login

Papers of the Week


2021 Apr 28


Int J Surg

Effects of parecoxib after pancreaticoduodenectomy: A single center randomized controlled trial.

Authors

Liu G, Ma Y, Chen Y, Zhuang Y, Yang Y, Tian X
Int J Surg. 2021 Apr 28:105962.
PMID: 33932589.

Abstract

Parecoxib, a selective cyclooxygenase-2 inhibitor, is a potential alternative analgesic to reduce opioid consumption after Pancreaticoduodenectomy (PD). Further, the safety and efficacy of long-term use of parecoxib for patients after PD remain a major concern.